|
|
Expert in Pharmaceutical Licensing, Life Science Licensing, Commercialization
Available for your Consulting and Expert Witness Needs
|
|
|
|
Summary of Expertise:
|
Listed with other top experts in: |
|
Expert has worked with a number of pharmaceutical and life science companies at senior level as either employee, consultant or interim manager, supporting initial public offerings and other fundraising activities and cross-border M&A. He has particular skills in due dilgence, valuation, market assessment, competetive inteligence and product positioning, which have been successfully applied in the licensing of a variety of pharmaceutical products and technologies, including early and late-stage cancer drugs, urology and sexual dysfunction drugs and in developing business stratgies appropriate for start-up and micro-cap companies. He is comfortable working with companies of all sizes.
|
|
Show Secondary and Basic Areas of Expertise |
| Year |
|
Degree |
|
Subject |
|
Institution |
|
Honors |
|
1985
|
|
PhD
|
|
Immunochemistry
|
|
CNAA
|
|
|
|
1979
|
|
BSc
|
|
Microbiology
|
|
Heriot-Watt University
|
|
Hons (2nd)
|
| Years |
|
Employer |
|
Department |
|
Title |
|
Responsibilities |
|
2000 to
|
|
(Undisclosed Consulting Company)
|
|
|
|
Principal
|
|
Executive and operational management of a small consulting practice active in pharmaceutical and life science commercial and corporate support and interim management
|
|
2004 to
|
|
(Undisclosed)
|
|
Business Development
|
|
Business Development Associate
|
|
Support for commercial activities (urology and sexual health product licensing), market modelling and fundraising support, new product identification, valuation, due diligence. UK listed company with US marketing operation.
|
|
2003 to 2005
|
|
BioImage A/S
|
|
Commercial
|
|
Chief Business Officer (Interim)
|
|
Privately held Danish company. Interim CBO responsible for outlicensing of preclinical cancer drug pipeline (successfully concluded 2005). Acquired 2006.
|
|
2001 to 2003
|
|
KS Biomedix
|
|
Business Development
|
|
Business Development Associate
|
|
UK listed company. Responsible for licensing of early and late stage biologics (oncology, inflammatory disease), inlicensing of complementary products and tecnologies. Company acquired by Xenova 2003 (managed transfer process)
|
|
2000 to 2001
|
|
Provalis plc
|
|
Therapeutics Research Division
|
|
Head of Business Development
|
|
UK listed company. Responsible for licensing and commercial management of vaccine technology portfolio, drug delivery technology.
|
| Publications: |
 |
Publications and Patents Summary
Patents in antiprotozal drug discovery and immunodiagnostic design, author of various reviews (DNA diagnostics, parasitology, antibiotic devleopment, urology)
|
| Selected Consulting Examples: |
-
Development of global licensing strategy and supporting collateral (valuation, competitor intelligence) for a novel male sexual health product
-
Valuation of intellectual property portfolio held by privatised arm of UK defense technology company, development of market models and licensing scenarios to support investment from a private equity fund
-
Licensing of consumer health medications and the enabling technology on behalf of a private US company
-
Analysis of opportunities, strategies and tactics appropriate to the acquisition of late-stage/marketed pharmaceutical products (CNS indications) on behalf of a listed UK company
-
Analysis of the portfolio held by a therapeutic vaccines company on behalf of a potential investor
|
|
Click the green button above to contact
Expert for a free initial screening call regarding your expert consulting needs.
Expert is available for consulting to corporate, legal and government clients.
Remember, your initial screening call to speak with
Expert is free.
|
|
Recent Litigation Client Requests:
|
-
Expert in medical antibiotics for consulting on patent reviews.
|
|
Click the green button above to contact
Expert for a free initial screening call regarding expert testimony,
litigation consulting and support, forensic services, or any related expert witness services.
A few litigation needs include product liability, personal injury, economic loss, intellectual property
(patent, trademark, trade secret, copyright), and insurance matters. Remember, your initial screening
call to speak with
Expert is free.
|
| International Experience: |
|
| Years |
|
Country / Region |
|
Summary |
|
2004 to 2005
|
|
Denmark
|
|
He served as Interim Chief Business Officer for BioImage A/S, a privately held drug discovery company in Copenagen
|
|
1997 to 2000
|
|
Sweden
|
|
Various, including operational management of Actinova's scientific personnel (Malmo) and business development for SBL Vaccin (Stockholm)
|
Ex-freelance writer for Frost & Sullivan, IMS Pharmastrategy
Click the green button above to contact
Expert for a free initial screening call regarding your marketing research, industry research, and company
research needs. For research needs involving multiple experts or secondary research,
a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker
and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.
Remember, your initial screening call to speak with
Expert is free.
|
| Additional Skills and Services: |
|
Other Skills and Services
Broad experience of early and late stage product and technology licensing in most major therapeutics categories (including consumer health), valuation, market modelling, due diligence associated with licensing and fundraising activities
|
|
Education
